Dr. Simola holds a M.S. in Pharmaceutical Chemistry and a Ph. D. in Pharmacology of Substance Abuse. Dr. Simola currently performs his research at the Department of Biomedical Sciences of the University of Cagliari. Dr. Simola’s research involves the study and development of new therapeutic agents for the treatment of Parkinson’s disease, focusing on adenosine receptor antagonists, the development of new preclinical models of early-stage Parkinson’s disease, and the study of the interactions between caffeine and other recreational psychostimulants. A recent field of research focuses on the study of ultrasonic vocalizations in rats as a tool for the study of the addictive properties of drugs.